MX9803605A - Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos. - Google Patents

Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos.

Info

Publication number
MX9803605A
MX9803605A MX9803605A MX9803605A MX9803605A MX 9803605 A MX9803605 A MX 9803605A MX 9803605 A MX9803605 A MX 9803605A MX 9803605 A MX9803605 A MX 9803605A MX 9803605 A MX9803605 A MX 9803605A
Authority
MX
Mexico
Prior art keywords
derivatives
arylsulphonyl
thio
carbonyl
aryl
Prior art date
Application number
MX9803605A
Other languages
English (en)
Spanish (es)
Inventor
Donald W Combs
Original Assignee
Johnson & Johnson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson filed Critical Johnson & Johnson
Publication of MX9803605A publication Critical patent/MX9803605A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06—Antiabortive agents; Labour repressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
    • C07D237/36—Benzo-cinnolines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX9803605A 1995-11-06 1998-05-06 Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos. MX9803605A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US790095P 1995-11-06 1995-11-06

Publications (1)

Publication Number Publication Date
MX9803605A true MX9803605A (es) 1998-09-30

Family

ID=21728709

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9803605A MX9803605A (es) 1995-11-06 1998-05-06 Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos.

Country Status (17)

Country Link
JP (1) JP2000501073A (no)
KR (1) KR100360614B1 (no)
CN (1) CN1110485C (no)
AU (1) AU704507B2 (no)
BR (1) BR9611407A (no)
CZ (1) CZ286789B6 (no)
HU (1) HU225162B1 (no)
IL (1) IL124320A (no)
MX (1) MX9803605A (no)
NO (1) NO310460B1 (no)
NZ (1) NZ319979A (no)
PL (1) PL185618B1 (no)
RU (1) RU2175969C2 (no)
TW (1) TW460467B (no)
UA (1) UA48989C2 (no)
WO (1) WO1997017332A1 (no)
ZA (1) ZA969298B (no)

Also Published As

Publication number Publication date
AU704507B2 (en) 1999-04-22
BR9611407A (pt) 1999-12-28
CN1110485C (zh) 2003-06-04
CZ286789B6 (en) 2000-07-12
KR100360614B1 (ko) 2003-06-02
CZ138098A3 (cs) 1998-09-16
PL326669A1 (en) 1998-10-12
CN1207091A (zh) 1999-02-03
TW460467B (en) 2001-10-21
HU225162B1 (en) 2006-07-28
PL185618B1 (pl) 2003-06-30
JP2000501073A (ja) 2000-02-02
AU7263796A (en) 1997-05-29
NO982030D0 (no) 1998-05-05
IL124320A (en) 2001-10-31
HUP0201305A2 (hu) 2002-12-28
NO310460B1 (no) 2001-07-09
HUP0201305A3 (en) 2003-02-28
NO982030L (no) 1998-06-23
IL124320A0 (en) 1998-12-06
NZ319979A (en) 1999-11-29
UA48989C2 (uk) 2002-09-16
ZA969298B (en) 1998-05-05
WO1997017332A1 (en) 1997-05-15
KR19990067340A (ko) 1999-08-16
RU2175969C2 (ru) 2001-11-20

Similar Documents

Publication Publication Date Title
CA2182183A1 (en) Treatment of ovarian estrogen dependent conditions
NZ325060A (en) Non peptide indole derivative and their use as antagonists of gonadotropin releasing hormone
IL124459A0 (en) Antagonists of gonadotropin releasing hormone
MX9804850A (es) Antagonistas de hormona liberadora de gonadotropina.
MY104065A (en) New pharmaceutical preparation
IL108958A0 (en) Sulfonate and carbamate derivatives of 3-aroylbenzo (b) thiophenes
FR2615095B1 (fr) Instrumentation d'osteosynthese pour la correction de scolioses lombaires par voie posterieure
IL127244A (en) Substituted amines, methods of their preparation and pharmaceutical compositions containing them
AU2561195A (en) Progesterone antagonists for the production of pharmaceutical agents for the treatment of dysfunctional uterine bleeding
EP0821587A4 (en) COMPOSITIONS, KITS AND METHODS FOR ADMINISTERING ANTILIPEMICS AND MEDICINES AGAINST PLATELET AGGREGATION
IL158871A0 (en) Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
HUP9901613A3 (en) Substituted tetracyclic fused furanamine derivatives, process for their preparation, use thereof and pharmaceutical compositions containing them
AP2001002054A0 (en) Use of biogenic estrogen sulfamates for hormone replacement therapy.
HUP9901190A3 (en) Sulfonamide derivatives of imidazole, process for producing them and pharmaceutical compositions containing them
BG102682A (en) System for the release of contraceptives having bactericidal and/or antiviral effect
MX9803605A (es) Derivados de 1-arilsulfonil- y aril(tio)carbonil-piridazino, y metodos para preparar los mismos.
IL147123A0 (en) Compositions containing soluble forms of hla-g for treating inflammatory skin pathologies
HUP9702480A3 (en) New polymorphous form of doxazosin-mesylate (form. i.), process for it's preparation and pharmaceutical compositions containing the same
CA2236896A1 (en) 1-arylsulphonyl, aryl(thio)carbonyl pyridazino derivatives and methods of preparation
ES2148742T3 (es) Dibenz(a,f)azulenos sustituidos y procedimientos de preparacion.
YU13902A (sh) Mezoprogestini (progesteron receptor modulatori) kao komponente kontraceptivnih sredstava za žene
MY118175A (en) Crystalline pharmaceutical product
HUP9702479A3 (en) New polymorphous form of doxazosin-mesylate (form ii.), process for it's preparation and pharmaceutical compositions containing the same
HUP9702477A3 (en) New polymorphous form of doxazosin-mesylate (form iii), process for it's preparation and pharmaceutical compositions containing the same
BG106078A (en) Thio-oxindole derivatives

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees